Status: Not yet recruiting
Efficacy and Safety of Antihypertensive Treatment With Mobile Stroke Units in Ultra-Early Intracerebral Hemorrhage
MSU-ICH is a prospective, multicenter, Week-wise-randomized, open-label, blinded-endpoint (PROBE) clinical trial comparing ultra-early prehospital blood pressure lowering delivered by a Mobile Stroke Unit (MSU) with standard Emergency Medical Services (EMS) in patients with spontaneous intracerebral hemorrhage.
Participants needed: 706
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Xuanwu Hospital, BeijingUpdated: Jun 24, 2026Locations: 1
Eligibility criteria
History and physical/neurological examination consistent with acute stroke. [+5]
Glasgow Coma Scale (GCS) score ≤5. [+3]